High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
- PMID: 35199042
- PMCID: PMC8844205
- DOI: 10.1016/j.euros.2021.07.010
High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
Similar articles
-
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.Eur Urol. 2020 May;77(5):614-627. doi: 10.1016/j.eururo.2020.01.033. Epub 2020 Mar 4. Eur Urol. 2020. PMID: 32146018
-
Role of robot-assisted radical prostatectomy in locally advanced prostate cancer.Int J Urol. 2018 Jan;25(1):30-35. doi: 10.1111/iju.13441. Epub 2017 Sep 13. Int J Urol. 2018. PMID: 28901630 Review.
-
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy.Minerva Urol Nefrol. 2019 Oct;71(5):508-515. doi: 10.23736/S0393-2249.19.03388-5. Epub 2019 Apr 5. Minerva Urol Nefrol. 2019. PMID: 30957475
-
The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer.J Clin Urol. 2016 Dec;9(2 Suppl):24-29. doi: 10.1177/2051415816654048. Epub 2016 Dec 1. J Clin Urol. 2016. PMID: 28344813 Free PMC article.
-
Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer.Transl Androl Urol. 2021 May;10(5):2178-2187. doi: 10.21037/tau-20-1002. Transl Androl Urol. 2021. PMID: 34159100 Free PMC article. Review.
Cited by
-
Prostate Cancer With Orbital Metastasis.Cureus. 2025 Mar 17;17(3):e80727. doi: 10.7759/cureus.80727. eCollection 2025 Mar. Cureus. 2025. PMID: 40242678 Free PMC article.
-
Poly I:C-priming of adipose-derived mesenchymal stromal cells promotes a pro-tumorigenic phenotype in an immunocompetent mouse model of prostate cancer.Front Cell Dev Biol. 2023 Nov 22;11:1145421. doi: 10.3389/fcell.2023.1145421. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38078010 Free PMC article.
References
-
- Soloway M., Roach M. Prostate cancer progression after therapy of primary curative intent: a review of data from prostate-specific antigen era. Cancer. 2005;104:2310–2322. - PubMed
LinkOut - more resources
Full Text Sources